Trial intelligence / Profile preview

Phase III first-line TAK-788 versus platinum-pemetrexed in EGFR exon 20 insertion non-small cell lung cancer

CTR20200164Phase 3Active

Sponsor

Millennium Pharmaceuticals

Start

Jun 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1